Potential therapeutic targets for neurokinin-1 receptor antagonists

By Duffy Ruth A  

Expert Opinion on Emerging Drugs, Vol. 9, Iss. 1, 2004-05 ,pp. : 9-21

Informa Healthcare

Access to resources Recommend Favorite

Potential Role of Platelet Glycoprotein IIb/IIIa Antagonists in Cerebrovascular Disorders

By Mousa S.A.  

CNS Drugs, Vol. 13, Iss. 3, 2000-03 ,pp. : 155-160

Adis International

Access to resources Recommend Favorite

Non-Peptidic CRF1 Receptor Antagonists for the Treatment of Anxiety,Depression and Stress Disorders

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 1, Iss. 5, 2002-10 ,pp. : 467-493

Bentham Science Publishers

Access to resources Recommend Favorite

Melanin-Concentrating Hormone MCH1 Receptor Antagonists: A Potential New Approach to the Treatment of Depression and Anxiety Disorders

By Shimazaki Toshiharu   Yoshimizu Takao   Chaki Shigeyuki  

CNS Drugs, Vol. 20, Iss. 10, 2006-01 ,pp. : 801-811

Adis International

Access to resources Recommend Favorite

Piperazino derivatives as neurokinin antagonists

By  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 7, 1997-07 ,pp. : 767-768

Informa Healthcare

Access to resources Recommend Favorite